Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jaclyn Y. Lock, Mariaelena Caboni, Philip Strandwitz, Madeleine Morrissette, Kevin DiBona, Brian A. Joughin, Kim Lewis & Rebecca L. Carrier. (2022) An in vitro intestinal model captures immunomodulatory properties of the microbiota in inflammation. Gut Microbes 14:1.
Read now
Read now
Articles from other publishers (20)
Susan A. Kennedy, Stephanie L. Annett, Margaret R. Dunne, Fiona Boland, Linda M. O’Neill, Emer M. Guinan, Suzanne L. Doyle, Emma K. Foley, Jessie A. Elliott, Conor F. Murphy, Annemarie E. Bennett, Michelle Carey, Daniel Hillary, Tracy Robson, John V. Reynolds, Juliette Hussey & Jacintha O’Sullivan. (2021) Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors. Frontiers in Oncology 11.
Crossref
Crossref
Marco Vincenzo Lenti & Antonio Di Sabatino. (2019) Intestinal fibrosis. Molecular Aspects of Medicine 65, pages 100-109.
Crossref
Crossref
Mayuree Rodrat, Kannikar Wongdee, Nattapon Panupinthu, Jirawan Thongbunchoo, Jarinthorn Teerapornpuntakit, Nateetip Krishnamra & Narattaphol Charoenphandhu. (2018) Prolonged exposure to 1,25(OH)2D3 and high ionized calcium induces FGF-23 production in intestinal epithelium-like Caco-2 monolayer: A local negative feedback for preventing excessive calcium transport. Archives of Biochemistry and Biophysics 640, pages 10-16.
Crossref
Crossref
Xinyang Song, Dai Dai, Xiao He, Shu Zhu, Yikun Yao, Hanchao Gao, Jingjing Wang, Fangfang Qu, Ju Qiu, Honglin Wang, Xiaoxia Li, Nan Shen & Youcun Qian. (2015) Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage. Immunity 43:3, pages 488-501.
Crossref
Crossref
Pissared Khuituan, Jarinthorn Teerapornpuntakit, Kannikar Wongdee, Panan Suntornsaratoon, Nipaporn Konthapakdee, Jintana Sangsaksri, Chanakarn Sripong, Nateetip KrishnamraNarattaphol Charoenphandhu. (2012)
Fibroblast growth factor-23 abolishes 1,25-dihydroxyvitamin D
3
-enhanced duodenal calcium transport in male mice
. American Journal of Physiology-Endocrinology and Metabolism 302:8, pages E903-E913.
Crossref
Crossref
Pablo M. Linares & Javier P. Gisbert. (2011) Role of growth factors in the development of lymphangiogenesis driven by inflammatory bowel disease. Inflammatory Bowel Diseases 17:8, pages 1814-1821.
Crossref
Crossref
John H. ChidlowJr.Jr., Deepti Shukla, Matthew B. Grisham & Christopher G. Kevil. (2007) Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. American Journal of Physiology-Gastrointestinal and Liver Physiology 293:1, pages G5-G18.
Crossref
Crossref
Inés D. Pousa, Javier P. Gisbert & José Maté. (2006) El desarrollo vascular en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 29:7, pages 414-421.
Crossref
Crossref
I. E. Koutroubakis, C. Xidakis, K. Karmiris, A. Sfiridaki, E. Kandidaki & E. A. Kouroumalis. (2006) Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease. European Journal of Clinical Investigation 36:2, pages 127-132.
Crossref
Crossref
Yesuf Taha. (2006) Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients. World Journal of Gastroenterology 12:43, pages 7012.
Crossref
Crossref
Matthew B. Grisham, F. Stephen Laroux & D. Neil Granger. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
177
196
.
Q. Gao, R. A. van Hogezand, C. B. H. W. Lamers & H. W. Verspaget. (2004) Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Alimentary Pharmacology & Therapeutics 20:5, pages 585-592.
Crossref
Crossref
Antonio Di Sabatino, Rachele Ciccocioppo, Elia Armellini, Raffaele Morera, Laura Ricevuti, Paolo Cazzola, Ilaria Fulle & Gino Roberto Corazza. (2004) Serum bFGF and VEGF Correlate Respectively with Bowel Wall Thickness and Intramural Blood Flow in Crohn’s Disease. Inflammatory Bowel Diseases 10:5, pages 573-577.
Crossref
Crossref
ARUN BHOWMIK, NIKU OKSALA, REINA ROIVAINEN, JARI KOISTINAHO, TIMO PAAVONEN, TAPIO HALME, HARRI MUSTONEN & HANNU PAIMELA. (2004) Regulation of restitution after superficial injury in isolated guinea pig gastric mucosa. APMIS 112:4-5, pages 225-232.
Crossref
Crossref
Hirofumi Yasui, Akira Andoh, Shigeki Bamba, Osamu Inatomi, Hideaki Ishida & Yoshihide Fujiyama. (2004) Role of Fibroblast Growth Factor-2 in the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Intestinal Myofibroblasts. Digestion 69:1, pages 34-44.
Crossref
Crossref
TOMOYUKI SHIRASAKA, MASAHIRO IIZUKA, MICHIHIRO YUKAWA, YOHEI HIRAI, YASUO HORIE, HIROAKI ITOU, SHIHO KON-NO, TSUNEO FUKUSHIMA & SUMIO WATANABE. (2003) Altered expression of epimorphin in ulcerative colitis. Journal of Gastroenterology and Hepatology 18:5, pages 570-577.
Crossref
Crossref
Teresa G. TessnerFilipe MuhaleSuzanne SchloemannSteven M. Cohn, Aubrey Morrison & William F. Stenson. (2003) Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase. American Journal of Physiology-Gastrointestinal and Liver Physiology 284:2, pages G269-G279.
Crossref
Crossref
Matthew B. Grisham, F. Stephen Laroux & D. Neil Granger. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
177
196
.
Michael Jeffers, William F. McDonald, Rajeev A. Chillakuru, Meijia Yang, Hiroshi Nakase, Lisa L. Deegler, Elizabeth D. Sylander, Beth Rittman, Alison Bendele, R.Balfour Sartor & Henri S. Lichenstein. (2002) A novel human fibroblast growth factor treats experimental intestinal inflammation. Gastroenterology 123:4, pages 1151-1162.
Crossref
Crossref
William F. Stenson. (2001) Mechanisms of tissue protection and repair in inflammatory bowel disease. Current Opinion in Gastroenterology 17:4, pages 313-317.
Crossref
Crossref